Benidipine counteracts sodium-induced alterations in systemic and regional hemodynamics

Blood Pressure

Volumn 6, Issue 1, 1997, Pages 18-23

  Shimamoto, Hiroyuki ^a,b   Shimamoto, Yoriko ^a  

^a PIA Nakamura Hospital   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENIDIPINE; NIFEDIPINE;

ADRENERGIC ACTIVITY; AGED; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER FLOWMETRY; ESSENTIAL HYPERTENSION; FEMALE; HEART INDEX; HEMODYNAMICS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SODIUM INTAKE;

EID: 0031017242     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059709086441     Document Type: Article

References (31)

1. Shimamoto H, Shimamoto Y. Nilvadipine increases cerebral blood flow in elderly hypertensives; comparison with nifedipine. J Human Hypertens 1995; 9: 271-9.
2. Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation; overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52: 584-94.
3. Campese VM. Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension. Am J Cardiol 1988; 62: 85G-91G.
4. Shimamoto H, Shimamoto Y. Terminal aortic response to sodium intake is the major determinant of total peripheral resistance in elderly hypertensives. J Human Hypertens 1992; 6: 353-8.
5. Shimamoto H, Shimamoto Y, Kito H, Kawazoe K, Fujita T, Okamoto M. Doppler echocardiographic measurement of cardiac output in man using mitral annulus method. J Clin Ultrasound 1992; 20: 263-70.
6. Shimamoto H, Kito H, Kawazoe K, Fujita T, Shimamoto Y. Quantitative pulsed Doppler measurement of arterial blood flows in humans. Vasc Surg 1992; 26; 408-14.
7. Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats. Arzneim-Forsch/Drug Res 1988; 38: 1684-90.
8. Fuji Y, Suzuki H, Katsumata H, Nakajima S, Saruta T. Hormonal and renal responses to oral once-daily calcium entry blocker in normotensive and hypertensive persons. J Cardiovasc Pharmacol 1988; 11: 438-43.
9. Karasawa A, Kubo K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol 1988; 47: 35-44.
10. Kiowski W, Bertel O, Erne P, Bolli P, Hulthèn UL, Ritz R, Bühler FR. Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine. Hypertension 1983; 5 Suppl I: I-70-1-74.
11. McLeay RAB, Stallard TJ, Watson RDS, Littler WA. The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation 1983; 67: 1084-90.
12. Raine AEG, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533-7.
13. Henry PD. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol 1980; 46: 1047-58.
14. Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats. Arzneim-Forsch/Drug Res 1988; 38: 1707-12
15. Karasawa A, Kubo K, Oka T, Nakamizo N. Effects of the new calcium antagonist benidipine hydrochloride on cardiohemodynamics in anesthetized dogs. Arzneim-Forsch/Drug Res 1988; 38: 1713-6.
16. Harashima H, Kiwada H, Kajita J, Kobayashi S. Effects of benidipine hydrochloride (Coniel®), a new calcium antagonist, on the cardiac output, regional blood flow and vascular resistance in conscious, spontaneously hypertensive rats. Biopharmceut Drug Deposit 1994; 15: 431-8.
17. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 1982; 21: 371-8.
18. Koolen MI, van Brummelen P. Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension 1984; 6: 820-5.
19. Altura BM, Altura BT. Vascular smooth muscle and neurohypophyseal hormones. Fed Proc 1977; 36: 1853-60.
20. Monos E, Cox RH, Peterson LH. Direct effect of physiological doses of arginine vasopressin on the arterial wall in vivo. Am J Physiol 1978; 234: H167-H172.
21. Morton JJ, Padfield PL. Vasopressin and hypertension in man. J Cardiovasc Pharmacol 1986; 8 Suppl 7: S101-S106.
22. Montani J-P, Liard J-F, Schoun J, Möhring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res 1980; 47: 346-55.
23. Bartelstone HJ, Nasmyth PA. Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip. Am J Physiol 1965; 208: 754-62.
24. McGrath JC. Evidence for more than one type of post-junctional α-adrenoceptor. Biochem Pharmacol 1982; 31: 467-84.
25. Shimamoto H, Bourreau J-P, Kwan CY, Daniel EE. Amplification of alpha adrenergic vasoconstriction in canine isolated mesenteric artery and vein. J Pharmacol Exp Ther 1992; 260: 1119-27.
26. Aiyar N, Nambi P, Stassen FL, Crooke ST. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci 1986; 39: 37-45.
27. Tabrizchi R, Triggle CR. Pressor actions of arginine vasopressin in pithed Sprague-Dawley, Wistar-Kyoto and spontaneously hypertensive rats before and after treatment with nifedipine or pertussis toxin. J Hypertens 1991; 9: 813-8.
28. 2+ dependence and diltiazem inhibition of contraction in rabbit conduit arteries and mesenteric resistance vessels. Blood Vessels 1984; 21: 23-31.
29. Erwald R, Wiechel KL. Effect of vasopressin on central and splanchnic hemodynamics in awake man. Acta Chir Scand 1978; 144: 347-58.
30. Charocopos F, Hatzinikolaou P, North WG, Gavras H. Systemic and regional hemodynamic effects of endogenous vasopressin stimulation in rats. Am J Physiol 1982; 243: H560-H565.
31. Heyndrickx GR, Boettcher DH, Vatner SF. Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 1976; 231: 1579-87.